Scholarlink

<p>In March 2025 the guidelines on <i>Gender incongruence and gender dysphoria in childhood and adolescence—Diagnostics and treatment (S2k) AWMF Register No. 028–014</i> were published. The aim was to provide all specialists in the healthcare system who encounter children and adolescents with nonconforming gender identity with an orientation for the best possible professionally informed care based on the latest medical knowledge. The assessment of the indications for interruption of an endogenous puberty and/or targeted sex hormone treatment is carried out by a&#xa0;specialist in child and adolescent psychiatry and psychotherapy, adolescent psychotherapy with proven clinical expertise. The somatic part of the indications should be carried out by an experienced pediatric endocrinological specialist with respect to the prerequisites (pubertal maturity stage, absence of somatic contraindications, etc.).</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Geschlechtsinkongruenz und Geschlechtsdysphorie im Kindes- und Jugendalter

  • 期刊论文

  • 发表日期：

    2026年3月13日

查看全文
  • Annette Richter-Unruh,
  • Achim Wüsthof,
  • Dagmar Pauli,
  • Thomas Lempp,
  • Georg Romer

摘要

In March 2025 the guidelines on Gender incongruence and gender dysphoria in childhood and adolescence—Diagnostics and treatment (S2k) AWMF Register No. 028–014 were published. The aim was to provide all specialists in the healthcare system who encounter children and adolescents with nonconforming gender identity with an orientation for the best possible professionally informed care based on the latest medical knowledge. The assessment of the indications for interruption of an endogenous puberty and/or targeted sex hormone treatment is carried out by a specialist in child and adolescent psychiatry and psychotherapy, adolescent psychotherapy with proven clinical expertise. The somatic part of the indications should be carried out by an experienced pediatric endocrinological specialist with respect to the prerequisites (pubertal maturity stage, absence of somatic contraindications, etc.).